These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

398 related items for PubMed ID: 19895991

  • 1. Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes.
    Zaba LC, Suárez-Fariñas M, Fuentes-Duculan J, Nograles KE, Guttman-Yassky E, Cardinale I, Lowes MA, Krueger JG.
    J Allergy Clin Immunol; 2009 Nov; 124(5):1022-10.e1-395. PubMed ID: 19895991
    [Abstract] [Full Text] [Related]

  • 2. TNF inhibition rapidly down-regulates multiple proinflammatory pathways in psoriasis plaques.
    Gottlieb AB, Chamian F, Masud S, Cardinale I, Abello MV, Lowes MA, Chen F, Magliocco M, Krueger JG.
    J Immunol; 2005 Aug 15; 175(4):2721-9. PubMed ID: 16081850
    [Abstract] [Full Text] [Related]

  • 3. Etanercept downregulates the Th17 pathway and decreases the IL-17+/IL-10+ cell ratio in patients with psoriasis vulgaris.
    Antiga E, Volpi W, Cardilicchia E, Maggi L, Filì L, Manuelli C, Parronchi P, Fabbri P, Caproni M.
    J Clin Immunol; 2012 Dec 15; 32(6):1221-32. PubMed ID: 22699761
    [Abstract] [Full Text] [Related]

  • 4. Keratinocyte overexpression of IL-17C promotes psoriasiform skin inflammation.
    Johnston A, Fritz Y, Dawes SM, Diaconu D, Al-Attar PM, Guzman AM, Chen CS, Fu W, Gudjonsson JE, McCormick TS, Ward NL.
    J Immunol; 2013 Mar 01; 190(5):2252-62. PubMed ID: 23359500
    [Abstract] [Full Text] [Related]

  • 5. Identification of cellular pathways of "type 1," Th17 T cells, and TNF- and inducible nitric oxide synthase-producing dendritic cells in autoimmune inflammation through pharmacogenomic study of cyclosporine A in psoriasis.
    Haider AS, Lowes MA, Suárez-Fariñas M, Zaba LC, Cardinale I, Khatcherian A, Novitskaya I, Wittkowski KM, Krueger JG.
    J Immunol; 2008 Feb 01; 180(3):1913-20. PubMed ID: 18209089
    [Abstract] [Full Text] [Related]

  • 6. Mechanisms of action of etanercept in psoriasis.
    Tan JK, Aphale A, Malaviya R, Sun Y, Gottlieb AB.
    J Investig Dermatol Symp Proc; 2007 May 01; 12(1):38-45. PubMed ID: 17502868
    [Abstract] [Full Text] [Related]

  • 7. TNFalpha and its receptors in psoriatic skin, before and after treatment with etanercept.
    Caldarola G, De Simone C, Carbone A, Tulli A, Amerio P, Feliciani C.
    Int J Immunopathol Pharmacol; 2009 May 01; 22(4):961-6. PubMed ID: 20074459
    [Abstract] [Full Text] [Related]

  • 8. Etanercept suppresses regenerative hyperplasia in psoriasis by acutely downregulating epidermal expression of interleukin (IL)-19, IL-20 and IL-24.
    Wang F, Smith N, Maier L, Xia W, Hammerberg C, Chubb H, Chen C, Riblett M, Johnston A, Gudjonsson JE, Helfrich Y, Kang S, Fisher GJ, Voorhees JJ.
    Br J Dermatol; 2012 Jul 01; 167(1):92-102. PubMed ID: 22458549
    [Abstract] [Full Text] [Related]

  • 9. Early tissue responses in psoriasis to the antitumour necrosis factor-α biologic etanercept suggest reduced interleukin-17 receptor expression and signalling.
    Johnston A, Guzman AM, Swindell WR, Wang F, Kang S, Gudjonsson JE.
    Br J Dermatol; 2014 Jul 01; 171(1):97-107. PubMed ID: 24601997
    [Abstract] [Full Text] [Related]

  • 10. Reduction of inflammatory slan (6-sulfo LacNAc) dendritic cells in psoriatic skin of patients treated with etanercept.
    Günther C, Blau K, Förster U, Viehweg A, Wozel G, Schäkel K.
    Exp Dermatol; 2013 Aug 01; 22(8):535-40. PubMed ID: 23879812
    [Abstract] [Full Text] [Related]

  • 11. Etanercept, a TNF antagonist for treatment for psoriatic arthritis and psoriasis.
    Mease PJ.
    Skin Therapy Lett; 2003 Jan 01; 8(1):1-4. PubMed ID: 12728284
    [Abstract] [Full Text] [Related]

  • 12. TNF-α inhibitors reduce the pathological Th1 -Th17 /Th2 imbalance in cutaneous mesenchymal stem cells of psoriasis patients.
    Campanati A, Orciani M, Lazzarini R, Ganzetti G, Consales V, Sorgentoni G, Di Primio R, Offidani A.
    Exp Dermatol; 2017 Apr 01; 26(4):319-324. PubMed ID: 27376466
    [Abstract] [Full Text] [Related]

  • 13. Etanercept in psoriasis.
    Papp KA.
    Expert Opin Pharmacother; 2004 Oct 01; 5(10):2139-46. PubMed ID: 15461549
    [Abstract] [Full Text] [Related]

  • 14. Integrative responses to IL-17 and TNF-α in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis.
    Chiricozzi A, Guttman-Yassky E, Suárez-Fariñas M, Nograles KE, Tian S, Cardinale I, Chimenti S, Krueger JG.
    J Invest Dermatol; 2011 Mar 01; 131(3):677-87. PubMed ID: 21085185
    [Abstract] [Full Text] [Related]

  • 15. Regulated genes in psoriatic skin during treatment with fumaric acid esters.
    Onderdijk AJ, Balak DM, Baerveldt EM, Florencia EF, Kant M, Laman JD, van IJcken WF, Racz E, de Ridder D, Thio HB, Prens EP.
    Br J Dermatol; 2014 Oct 01; 171(4):732-41. PubMed ID: 24852654
    [Abstract] [Full Text] [Related]

  • 16. Dissecting the psoriasis transcriptome: inflammatory- and cytokine-driven gene expression in lesions from 163 patients.
    Swindell WR, Johnston A, Voorhees JJ, Elder JT, Gudjonsson JE.
    BMC Genomics; 2013 Aug 01; 14():527. PubMed ID: 23915137
    [Abstract] [Full Text] [Related]

  • 17. Differential expression of phosphorylated NF-kappaB/RelA in normal and psoriatic epidermis and downregulation of NF-kappaB in response to treatment with etanercept.
    Lizzul PF, Aphale A, Malaviya R, Sun Y, Masud S, Dombrovskiy V, Gottlieb AB.
    J Invest Dermatol; 2005 Jun 01; 124(6):1275-83. PubMed ID: 15955104
    [Abstract] [Full Text] [Related]

  • 18. Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses.
    Zaba LC, Cardinale I, Gilleaudeau P, Sullivan-Whalen M, Suárez-Fariñas M, Fuentes-Duculan J, Novitskaya I, Khatcherian A, Bluth MJ, Lowes MA, Krueger JG.
    J Exp Med; 2007 Dec 24; 204(13):3183-94. PubMed ID: 18039949
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Etanercept for psoriasis: two case reports.
    Fidalgo A, Baptista J, Rocha Páris F, Caldas Lopes L, Ferreira A.
    Int J Clin Pharmacol Res; 2005 Dec 24; 25(4):159-63. PubMed ID: 16402631
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.